Dronabinol is assessed like a pregnancy Group C drug, mainly because it hasn't exhibited teratogenic outcomes in animal designs at doses starting from 0.2 to 5 periods the most encouraged human dose. However, it is crucial to notice that pregnant sufferers have not been subjected to sufficie